Find Etonogestrel manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

11 RELATED EXCIPIENT COMPANIES

18EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Implanon, 54048-10-1, 3-oxodesogestrel, Nexplanon, 3-ketodesogestrel, 3-keto-desogestrel
Molecular Formula
C22H28O2
Molecular Weight
324.5  g/mol
InChI Key
GCKFUYQCUCGESZ-BPIQYHPVSA-N
FDA UNII
304GTH6RNH

Etonogestrel
Etonogestrel is a synthetic form of the naturally occurring female sex hormone progesterone. Etonogestrel binds to the cytoplasmic progesterone receptors in the reproductive system and subsequently activates progesterone receptor mediated gene expression. As a result of the negative feedback mechanism, luteinizing hormone (LH) release is inhibited, which leads to an inhibition of ovulation and an alteration in the cervical mucus and endometrium.
Etonogestrel is a Progestin.
1 2D Structure

Etonogestrel

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
2.1.2 InChI
InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1
2.1.3 InChI Key
GCKFUYQCUCGESZ-BPIQYHPVSA-N
2.1.4 Canonical SMILES
CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
2.1.5 Isomeric SMILES
CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
2.2 Other Identifiers
2.2.1 UNII
304GTH6RNH
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 13-ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one

2. 18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17-alpha)-

3. 3-keto-desogestrel

4. 3-ketodesogestrel

5. 3-oxo Desogestrel

6. 3-oxodesogestrel

7. Implanon

8. Nexplanon

9. Org-3236

2.3.2 Depositor-Supplied Synonyms

1. Implanon

2. 54048-10-1

3. 3-oxodesogestrel

4. Nexplanon

5. 3-ketodesogestrel

6. 3-keto-desogestrel

7. Org-3236

8. Org 3236

9. (8s,9s,10r,13s,14s,17r)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one

10. 304gth6rnh

11. Chebi:50777

12. 18,19-dinorpregn-4-en-20-yn-3-one,13-ethyl-17-hydroxy-11-methylene-, (17a)-

13. Etonogestrelum

14. Implanon (tn)

15. Etonogestrel (usan/inn)

16. Unii-304gth6rnh

17. Etonogestrel [usan:inn:ban]

18. Ncgc00168777-01

19. Einecs 258-936-2

20. 17-ethinyl-17-beta-hydroxy-18-methyl-11-methylene-4-estren-3-one

21. Etonogestrel [mi]

22. Etonogestrel [inn]

23. Etonogestrel [usan]

24. 13-ethyl-17-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one

25. Chembl1531

26. Dsstox_cid_26782

27. Dsstox_rid_81900

28. Etonogestrel [vandf]

29. Dsstox_gsid_46782

30. Desogestrel Impurity D

31. Etonogestrel [mart.]

32. Desogestrel Related Compound C

33. Etonogestrel [usp-rs]

34. Etonogestrel [who-dd]

35. Schembl117703

36. Gtpl7590

37. Dtxsid9046782

38. Etonogestrel (3-ketodesogestrel)

39. Etonogestrel, >=98% (hplc)

40. Etonogestrel [orange Book]

41. Bcp28481

42. Hy-b0652

43. 3-oxodesogestrel;3-keto-desogestrel

44. Tox21_112638

45. Bdbm50423516

46. S4673

47. Zinc11680067

48. Nuvaring Component Etonogestrel

49. 13-ethyl-11-methylene-18,19-dinor-17-alpha-pregn-4-en-20-yn-3-one

50. 17alpha-ethynyl-17beta-hydroxy-11-methylidene-18a-homo-estr-4-en-3-one

51. Ccg-267753

52. Db00294

53. (17-alpha)-13-ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one

54. (17alpha)-13-ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one

55. 18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-, (17-alpha)-

56. Etonogestrel Component Of Nuvaring

57. Ncgc00168777-04

58. As-73246

59. Cas-54048-10-1

60. Desogestrel Impurity D [ep Impurity]

61. C75537

62. D04104

63. Desogestrel Related Compound C [usp-rs]

64. 048e101

65. A829925

66. Q3733839

67. Etonogestrel, United States Pharmacopeia (usp) Reference Standard

68. (17-alpha)-13-ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-on

69. 13-ethyl-17-hydroxy-11-methylene-18,19-dinor-17.alpha.-pregn-4-en-20-yn-3-one

70. 18,19-dinor-17alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-

71. Desogestrel Related Compound C, United States Pharmacopeia (usp) Reference Standard

72. (1r,3as,3bs,9ar,9bs,11as)-11a-ethyl-1-ethynyl-1-hydroxy-10-methylidene-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

73. (1s,2r,10s,11s,14r,15s)-15-ethyl-14-ethynyl-14-hydroxy-17-methylidenetetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

74. (8s,9s,13s,14s,17r)-13-ethyl-17-ethynyl-17-hydroxy-11-methylene-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3(2h)-one

75. 13-ethyl-17-hydroxy-11-methylidene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one (3-ketodesogestrel)

76. 18,19-dinor-17.alpha.-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-11-methylene-

2.4 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 324.5 g/mol
Molecular Formula C22H28O2
XLogP33.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass324.208930132 g/mol
Monoisotopic Mass324.208930132 g/mol
Topological Polar Surface Area37.3 Ų
Heavy Atom Count24
Formal Charge0
Complexity677
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameImplanon
PubMed HealthEtonogestrel (Implantation)
Drug ClassesContraceptive, Progestin
Drug LabelIMPLANON (etonogestrel implant) is a progestin-only, soft, flexible implant preloaded in a sterile, disposable applicator for subdermal use. The implant is off-white, non-biodegradable and 4 cm in length with a diameter of 2 mm (see Figure 22). Each...
Active IngredientEtonogestrel
Dosage FormImplant
RouteImplantation
Strength68mg/implant
Market StatusPrescription
CompanyOrganon Usa

2 of 4  
Drug NameNexplanon
PubMed HealthEtonogestrel (Implantation)
Drug ClassesContraceptive, Progestin
Drug LabelNEXPLANON is a radiopaque, progestin-only, soft, flexible implant preloaded in a sterile, disposable applicator for subdermal use. The implant is white/off-white, non-biodegradable and 4 cm in length with a diameter of 2 mm (see Figure 18). Each impl...
Active IngredientEtonogestrel
Dosage FormImplant
RouteImplantation
Strength68mg/implant
Market StatusPrescription
CompanyOrganon Usa

3 of 4  
Drug NameImplanon
PubMed HealthEtonogestrel (Implantation)
Drug ClassesContraceptive, Progestin
Drug LabelIMPLANON (etonogestrel implant) is a progestin-only, soft, flexible implant preloaded in a sterile, disposable applicator for subdermal use. The implant is off-white, non-biodegradable and 4 cm in length with a diameter of 2 mm (see Figure 22). Each...
Active IngredientEtonogestrel
Dosage FormImplant
RouteImplantation
Strength68mg/implant
Market StatusPrescription
CompanyOrganon Usa

4 of 4  
Drug NameNexplanon
PubMed HealthEtonogestrel (Implantation)
Drug ClassesContraceptive, Progestin
Drug LabelNEXPLANON is a radiopaque, progestin-only, soft, flexible implant preloaded in a sterile, disposable applicator for subdermal use. The implant is white/off-white, non-biodegradable and 4 cm in length with a diameter of 2 mm (see Figure 18). Each impl...
Active IngredientEtonogestrel
Dosage FormImplant
RouteImplantation
Strength68mg/implant
Market StatusPrescription
CompanyOrganon Usa

4.2 Drug Indication

Etonogestrel is administered in subdermal implants as long-acting reversible contraception. It is known to be effective in postpartum insertion including breastfeeding women. Etonogestrel is part of the long-acting contraceptive implants that prevent pregnancy. The implant's effect can remain for 5 years.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Etonogestrel attains its therapeutic effect inhibiting fertility by impairing the release of the luteinizing hormone which is one of the most important reproductive hormones for ovulation. As well, etonogestrel is known to increase the viscosity of the cervical mucus hindering the passage of the spermatozoa and altering the lining in the uterus to prevent the implantation of the fertilized eggs in the endometrium. In clinical trials, etonogestrel was implanted and reported to avoid 100% of pregnancies over a three year period. When the implant was removed, normal periods were reinstalled within 90 days in 91% of the individuals. Fertility was established quickly with 20 reported pregnancies within 3 months of implant removal. The implants of etonogestrel release 40 mcg of etonogestrel daily and they usually provide a continuous contraception effect for 3 years. When the implant is administered, the failure rate is reported to be 0.1%. Some non-contraceptive effects are improved dysmenorrhea. All data of etonogestrel comes from patients between 80-130% of the body mass.


5.2 MeSH Pharmacological Classification

Contraceptive Agents, Female

Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)


Contraceptive Agents, Hormonal

Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
ETONOGESTREL
5.3.2 FDA UNII
304GTH6RNH
5.3.3 Pharmacological Classes
Progestin [EPC]; Progesterone Congeners [CS]
5.4 ATC Code

G03AC08

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


G - Genito urinary system and sex hormones

G03 - Sex hormones and modulators of the genital system

G03A - Hormonal contraceptives for systemic use

G03AC - Progestogens

G03AC08 - Etonogestrel


5.5 Absorption, Distribution and Excretion

Absorption

Vaginal administration of etonogestrel is known to be significantly absorbed through the vaginal epithelium but it does not increase the levels of etonogestrel in the urine. On the other hand, oral administration is absorbed in the GI tract and it goes through the first-pass metabolism. When etonogestrel is administered subdermally it is absorbed rapidly into the bloodstream and it presents a bioavailability of 82%. It is reported that the implant releases around 60 mcg per day in the first 3 months and then decreases steady reaching a concentration of 30 mcg at the end of year 2.


Route of Elimination

The elimination of etonogestrel and its metabolites is mainly done renally.


Volume of Distribution

The apparent volume of distribution of etonogestrel is of around 201 L.


Clearance

The clearance rate of etonogestrel is reported to be of 7.5 L/h.


5.6 Metabolism/Metabolites

Etonogestrel is highly metabolized in the liver by the action of the cytochrome isoenzyme 3A4 mainly by the presence of hydroxylation, sulfate conjugation and glucuronide conjugation reactions.


5.7 Biological Half-Life

The elimination half-life of etonogestrel is reported to be of 25 hours which indicates a reversible contraceptive effect.


5.8 Mechanism of Action

Etonogestrel binds with high affinity to the progesterone and estrogen receptors in the target organs. From the target organs, they include the female reproductive tract, mammary gland, hypothalamus, and pituitary. Once bound, this drug changes the synthesis of different proteins which in order decreases the level of gonadotropin-releasing hormone and the luteinizing hormone.


API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"ETONOGESTREL","year":"2021","qtr":"Q1","strtotime":1613068200,"product":"ETONOGESTREL (QTY : 11X100MG, PRICE: USD-787.00)(FOC)","address":"106, FIRST FLOOR , ASHOKA BHOOPALCHAMBERS BEGUMPET, S.P. ROAD,","city":"HYDERABAD-A.P.","supplier":"USP","supplierCountry":"INDIA","foreign_port":"WASHINGTON DULLES I","customer":"UNITED STATES PHARMACOPEIA ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0011","unit":"KGS","unitRateFc":"7870000","totalValueFC":"9092.1","currency":"USD","unitRateINR":"601787972.7","date":"12-Feb-2021","totalValueINR":"661966.77","totalValueInUsd":"9092.1","indian_port":"HYDERABAD AIR","hs_no":"29372300","bill_no":"2736280","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON DULLES I","supplierAddress":"","customerAddress":"106, FIRST FLOOR , ASHOKA BHOOPALCHAMBERS BEGUMPET, S.P. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649874600,"product":"ETONOGESTREL (QTY:1X100 MG,PRICE: USD 811)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0001","unit":"KGS","unitRateFc":"8110000","totalValueFC":"848.6","currency":"USD","unitRateINR":"640230700","date":"14-Apr-2022","totalValueINR":"64023.07","totalValueInUsd":"848.6","indian_port":"HYDERABAD AIR","hs_no":"29372300","bill_no":"8276555","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676053800,"product":"ETONOGESTREL (QTY:1 X 100 MG, PRICE USD:852)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"USP","supplierCountry":"CHINA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0001","unit":"KGS","unitRateFc":"8520000","totalValueFC":"875.9","currency":"USD","unitRateINR":"723365200","date":"11-Feb-2023","totalValueINR":"72336.52","totalValueInUsd":"875.9","indian_port":"HYDERABAD AIR","hs_no":"29372300","bill_no":"4600511","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722623400,"product":"ETONOGESTREL MICRONIZED (F.O.C.)","address":"13, SURYODAYA MILL ESTATE,","city":"MUMBAI ,MAHARASHTRA","supplier":"ASPEN API","supplierCountry":"NETHERLANDS","foreign_port":"AMSTERDAM, SCHIPHOL","customer":"PREGNA INTERNATIONAL LIMITED","customerCountry":"INDIA","quantity":"0.05","actualQuantity":"50","unit":"GMS","unitRateFc":"75","totalValueFC":"4124.3","currency":"EUR","unitRateINR":"6918.8","date":"03-Aug-2024","totalValueINR":"345937.5","totalValueInUsd":"4124.3","indian_port":"Bombay Air","hs_no":"29372300","bill_no":"4868651","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Micronized","supplierPort":"AMSTERDAM, SCHIPHOL","supplierAddress":"Kloosterstraat 6 5349 AB OssSDNFSDNF NETHERLANDS","customerAddress":"13, SURYODAYA MILL ESTATE,"}]
12-Feb-2021
03-Aug-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - RING;VAGINAL - 0.015MG/24HR;0.12MG/2...DOSAGE - RING;VAGINAL - 0.015MG/24HR;0.12MG/24HR

USFDA APPLICATION NUMBER - 21187

read-more

DOSAGE - IMPLANT;IMPLANTATION - 68MG/IMPLANT

USFDA APPLICATION NUMBER - 21529

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Lubricants & Glidants

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Emulsifying Agents

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Direct Compression

read-more
read-more

Controlled & Modified Release

read-more
read-more

Co-Processed Excipients

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty